FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

784837009: Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3765581015 Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution en Synonym Active Only initial character case insensitive SNOMED CT core module
3765582010 Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator unit Milliliter true Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator unit Milliliter true Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has manufactured dose form Conventional release eye solution true Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Is a Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value 5 false Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value 15 false Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance Hydrocortisone acetate true Inferred relationship Existential restriction modifier 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance Neomycin true Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start